Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

Monday - Friday, 6:00 - 7:00 PM ET Axon Enterprise CEO Rick Smith told CNBC's Jim Cramer on Wednesday how the company, which makes technology and equipment for law enforcement, is trying to help ...

Axon, a public safety technology provider, announced it has completed its acquisition of Dedrone, an airspace security company. Axon’s intention to acquire Dedrone was first announced in May 2024 and ...

Axon has long served law enforcement agencies, but it's expanding into new markets. The company has almost tripled its net income in the last three years. Management estimates its total addressable ...

Axon Enterprise (NASDAQ: AXON) stock is getting hit with sell-offs in Thursday's trading. The company's share price was down 5.5% as of 2:10 p.m. ET and had been down as much as 8.9% earlier in the ...

In recent months, Axon Enterprise moved to redeem all of its 0.50% convertible senior notes due 2027 early, while also pursuing debt repurchase options to reshape its balance sheet and funding mix. At ...

Axon is down 20% from the all-time high it reached earlier this year. The company is seeing significant interest in its generative AI product, Draft One. Management expects revenue to grow 25% this ...